BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Taha B, Winston G, Tosi U, Hartley B, Hoffman C, Dahmane N, Mason CE, Greenfield JP. Missing diversity in brain tumor trials. Neurooncol Adv 2020;2:vdaa059. [PMID: 32642711 DOI: 10.1093/noajnl/vdaa059] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Zreik J, Kerezoudis P, Alvi MA, Yolcu YU, Kizilbash SH. Disparities in Reported Testing for 1p/19q Codeletion in Oligodendroglioma and Oligoastrocytoma Patients: An Analysis of the National Cancer Database. Front Oncol 2021;11:746844. [PMID: 34858822 DOI: 10.3389/fonc.2021.746844] [Reference Citation Analysis]
2 Lavery JA, Callahan MK, Panageas KS. Apples and Oranges? Considerations for EHR-Based Analyses Aggregating Data From Interventional Clinical Trials and Point-of-Care Encounters in Oncology. JCO Clin Cancer Inform 2021;5:21-3. [PMID: 33411618 DOI: 10.1200/CCI.20.00096] [Reference Citation Analysis]